Blood Lead Screenings

October 24 – 30, 2021 is Lead Poisoning Prevention Week. About 3.3 million American families have children under 6 years of age at risk of exposure to lead. Medicaid and CHIP cover blood lead screening tests for children. Families and Campaign partners can get more information here: CDC - National Lead Poisoning Prevention Week

U.S. flag U.S. flag

An official website of the United States government

Data Report Shows Vulnerable Children and Teens Forgoing Mental Health Care During COVID-19 Public Health Emergency

Data recently released by The Centers for Medicare & Medicaid Services (CMS) highlights the continued impact the COVID-19 Public Health Emergency (PHE) is having on Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries and utilization of health services. The data show that, from March through October 2020, beneficiaries have foregone millions of primary, preventive, and mental health care visits due to the COVID-19 PHE, compared to the same time period in 2019. Although utilization rates for some treatments have rebounded to pre-pandemic levels, mental health services show the slowest rebound.

This decline in utilization is occurring at a time when preliminary evidence shows mental health conditions have worsened nationwide. The gap in service utilization due to the PHE, particularly for mental health services, may have a substantial impact on long-term health outcomes. Medicaid and CHIP-funded mental health services, in addition to primary and preventative services, cover the majority of children, people living in poverty, and those with special health care needs. Medicaid and CHIP also cover millions of racial and ethnic minorities.

The Connecting Kids to Coverage National Campaign, a national outreach and enrollment initiative funded under the Children's Health Insurance Program Reauthorization Act (CHIPRA) and the Affordable Care Act, has recently launched a Mental Health Initiative, which includes a digital video, print materials and social media graphics that promote mental health services, which are covered under Medicaid and CHIP.

Additional Data Highlights

Specifically, the data demonstrate a 34% decline in the number of mental health services utilized by children under age 19, compared to the same time period in 2019, and 22% decline in the number of mental health services utilized by adults aged 19 to 64, compared to the same time period in 2019. This translates to approximately 14 million fewer mental health services for children and approximately 12 million fewer mental health services for adults, for a total of nearly 26 million fewer mental health services utilized across both groups. Similarly, although there are preliminary reports of increased drug-related mortality due to the COVID-19 PHE, substance use disorder service utilization fell by 3.6 million services (13% decline) when compared to the same time period in 2019. 

It is important to note that the data show that utilization rates for certain primary and preventive services for children under age 19 have recovered to pre-pandemic levels, or have started to rebound across many areas of the country. While this recovery is encouraging, millions of services still need to be delivered to make up for those missed between March and October 2020. Preliminary 2020 data shows 9% fewer childhood vaccinations for beneficiaries under age two (1.8 million services), 21% fewer child screening services (4.6 million services) among children under age 19, and 39% fewer dental services (11.4 million services) among children under age 19 when compared to pre-pandemic levels. This data takes into account increases in services delivered through telehealth.

Throughout the pandemic, CMS has encouraged states to consider telehealth options to combat COVID-19 and increase access to care. This updated data snapshot demonstrates a marked increase in the number of services delivered via telehealth compared to prior years. The number of services delivered via telehealth surged 2,700% during the PHE to nearly 68 million between March and October 2020. However, this increase has not been enough to offset the overall decline in service utilization.

For COVID-19 treatment and acute care use, the preliminary findings show more than 1.2 million Medicaid and CHIP beneficiaries received COVID-19 treatment, and nearly 124,000 were hospitalized through October 2020. Despite significant variance across states regarding this data, preliminary results suggest that the COVID-19 treatment rate increases with age. In addition, Medicaid and CHIP paid for nearly 10 million COVID-19 tests or testing related services, although this data does not include tests provided free of charge or covered by other insurance programs, including Medicare.

View the press release, fact sheet and data report for additional information.